News Feed
OncoDaily Pulse
OncoGrants
OncoDaily TV
NewsLetter
Voices
Not To Miss
FDA Approvals
New Paper Alert
OncoDaily 100
Community
OncoDaily Magazine
Career Updates
Oncology Drugs
Dialogues
Stories

Celebrities and Cancer
Cancer Types
Radiotherapy
Science
Trial Updates
ASCO
ESMO
ESO
MASCC
Cancer Center Near Me
Immune Oncology
Oncologist Near Me
OncoDaily Party 2025

Childhood Cancer
Health Policy
Hall of Fame
OncoIndustry
Public Health
Oncology Tech
Blog Posts
BIGR
Global Cancer Movement
History
Oncolibrary
OncoThon 2025
Yvonne Award 2025

Jan / 2026

January 2026
M	T	W	T	F	S	S
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

« Dec

OncoDaily IO OncoDaily GI Hemostasis Today Fertility News

Voices
Not To Miss
FDA Approvals
New Paper Alert
OncoDaily 100
Community
OncoDaily Magazine
Career Updates
Oncology Drugs
Dialogues
Stories

News Feed
OncoDaily Pulse
OncoGrants
OncoDaily TV
NewsLetter

ASCO Congratulates 2026 Special Award Recipients

ASCO Congratulates 2026 Special Award Recipients

How I Treat Cervical cancer in 2026: OncoDaily Summit

How I Treat Cervical cancer in 2026: OncoDaily Summit

CancerWorld Issue #111 (January) is Live!

CancerWorld Issue #111 (January) is Live!

Tedros Adhanom Ghebreyesus: A Powerful Tool to Protect Health and Fund Sustainable Systems

Tedros Adhanom Ghebreyesus: A Powerful Tool to Protect Health and Fund Sustainable Systems

DRAGON Trial: Linavonkibart + Pembrolizumab in PD-1–Resistant Solid Tumors

DRAGON Trial: Linavonkibart + Pembrolizumab in PD-1–Resistant Solid Tumors

Ramy Sedhom: Embedding Geriatric Oncology in a Community Practice

Ramy Sedhom: Embedding Geriatric Oncology in a Community Practice

Ghassan Abou-Alfa: The New Standard for Screening Abbreviated MRI Plus AFP

Ghassan Abou-Alfa: The New Standard for Screening Abbreviated MRI Plus AFP

First Stakeholder Webcast of 2026 on BOT+BAL Access and Updates - Agenus

First Stakeholder Webcast of 2026 on BOT+BAL Access and Updates - Agenus

Bing Z. Carter

Nov 23, 2025 4:42 pm

Voices

Talha Badar: Achieving Effective AML Cell Death with p53 Restoration and MDM2/BCL2 or XPO1 Inhibitors

Talha Badar

Jul 17, 2025 4:07 pm

Insight

How to Detect and Treat Difficult Cancers – MD Anderson Cancer Center

Difficult Cancers

May 23, 2025 6:34 am

Blog Posts

Naveen Pemmaraju: SMAC Mimetics as Potential Cancer Therapeutics in Myeloid Malignancies

Naveen Pemmaraju

Aug 4, 2024 10:17 am

Blog Posts

Naveen Pemmaraju: Intersection of neurosurgery and leukemia from two Johns Hopkins alums

neurosurgery

Headlines

USA–Saudi Biotech Alliance Summit Marks a New Era in Healthspan, Immunotherapy, and Global Scientific Partnership

Emil Lou: Targeting the Tumor Microenvironment in Pancreatic Cancer - Interim ACCENT Trial Results

Julie Gralow on the Importance of House and Senate Bipartisan Vote to Increase NIH and NCI Funding for 2026

Evandro de Azambuja: ESMO-ESTRO Guidance on Radiotherapy with Targeted Therapies

Karen Canfell: $13.1M Boost for Cervical Cancer Elimination in the Indo-Pacific

CancerWorld OncoDaily Medical Journal Hemostasis Today OncoDaily IO OncoDaily GI OncoDailyTV

OncoDaily™ | © 2023 - 2025

All rights reserved. Unauthorized reproduction, distribution, or transmission of any content on OncoDaily.com is strictly prohibited. For permission requests or inquiries, please contact OncoDaily directly. By accessing and using OncoDaily.com, you acknowledge and agree to comply with this copyright notice, as well as our Privacy Policy, Editorial Policy, Cookie Policy, and Disclaimer. Continued use of this website constitutes acceptance of all such terms and policies.

Phone number: +1 978 717 48 84

Email: info@oncodaily.com

About Privacy Policy Editorial Policy Cookie Policy Disclaimer

Crafted by Matemat

Oncology OncoDaily cancer fight against cancer Global fight against cancer Breast Cancer cancer care ASCO Lung cancer Cancer research ESMO Headlines MD Anderson Cancer Center immunotherapy NSCLC cancer awareness cancer treatment Research ASCO24 colorectal cancer Childhood Cancer clinical trials AACR prostate cancer FDA UICC Dana-Farber Cancer Institute American Cancer Society European Cancer Organisation SIOP NCI chemotherapy Myeloma Robert Orlowski National Cancer Institute American Society of Clinical Oncology Vivek Subbiah Myeloma Paper of the Day healthcare Paolo Tarantino Pancreatic Cancer AI IASLC ASCO25 radiation oncology cervical cancer WHO multiple myeloma Zainab Shinkafi-Bagudu Memorial Sloan Kettering Cancer Center

European School of Oncology

Sitemap

Manage Cookie Consent

To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Manage options
Manage services
Manage {vendor_count} vendors
Read more about these purposes

View preferences

{title}
{title}
{title}

Manage Cookie Consent

To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Manage options
Manage services
Manage {vendor_count} vendors
Read more about these purposes

View preferences

{title}
{title}
{title}